Efficiency of once-weekly subcutaneous administration of recombinant human erythropoietin versus th ree times a week administration in hemodialysis patients

被引：20

作者：

Lago, M

PerezGarcia, R

deVinuesa, MSG

Anaya, F

Valderrabano, F

机构：

[1] Nephrology Department, Hospital General Universitario ‘Gregorio Maranon’, Madrid

来源：

NEPHRON | 1996年 / 72卷 / 04期

关键词：

D O I：

10.1159/000188977

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：723 / 724

页数：2

共 5 条

[1] CORRECTION OF THE ANEMIA OF END-STAGE RENAL-DISEASE WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN - RESULTS OF A COMBINED PHASE-I AND PHASE-II CLINICAL-TRIAL [J].

ESCHBACH, JW ;

EGRIE, JC ;

DOWNING, MR ;

BROWNE, JK ;

ADAMSON, JW .

NEW ENGLAND JOURNAL OF MEDICINE, 1987, 316 (02) :73-78

[2]

HORL WH, 1992, ACTA HAEMATOL-BASEL, V87, P16

[3] ONCE WEEKLY VERSUS TWICE WEEKLY SUBCUTANEOUS ADMINISTRATION OF RECOMBINANT-HUMAN-ERYTHROPOIETIN IN HEMODIALYSIS-PATIENTS [J].

LUI, SF ;

WONG, KC ;

LI, PKT ;

LAI, KN .

AMERICAN JOURNAL OF NEPHROLOGY, 1992, 12 (1-2) :55-60

[4]

LUI SF, 1991, CLIN NEPHROL, V36, P246

[5] EFFECT OF HUMAN ERYTHROPOIETIN DERIVED FROM RECOMBINANT-DNA ON THE ANEMIA OF PATIENTS MAINTAINED BY CHRONIC-HEMODIALYSIS [J].

WINEARLS, CG ;

PIPPARD, MJ ;

DOWNING, MR ;

OLIVER, DO ;

REID, C ;

COTES, PM .

LANCET, 1986, 2 (8517) :1175-1178

← 1 →